Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes

被引:37
作者
Conconi, A
Bertoni, F
Pedrinis, E
Motta, T
Roggero, E
Luminari, S
Capella, C
Bonato, M
Cavalli, F
Zucca, E
机构
[1] Oncol Inst So Switzerland, Div Med Oncol, Bellinzona, Switzerland
[2] St Bartholomews & Royal London Sch Med & Dent, Dept Expt Hematol, London, England
[3] Ist Cantonale Patol, Locamo, Switzerland
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[5] Univ Statale Milano, Osped Maggiore, IRCCS, Serv Ematol, Milan, Italy
[6] Univ Insubria, Ist Anat & Istol Patol, Varese, Italy
关键词
D O I
10.1182/blood.V98.3.781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodal marginal zone B-cell lymphoma (MZL) is a rare and not extensively studied entity that accounts for approximately 2% of all non-Hodgkin lymphomas. Complementarity-determining regions 2 and 3 (CDR2, CDR3) of the immunoglobulin heavy-chain variable region (V-H) genes were amplified by polymerase chain reaction (PCR), cloned, and sequenced in 8 patients with nodal MZL. All showed a potentially functional V-H rearrangement. The use of V-H gene families was unbiased and without overrepresentation of any particular V-H gene or gene family. The presence of somatic V-H mutations was detected, with a deviation from the closest germ line sequence ranging from 4% to 17% in 6 of 8 patients. In 3 mutations, the replacement-to-silent mutation ratio suggested the presence of an antigen-selected process. Sequencing different subclones of the same cloned PCR products allowed the detection of intraclonal variability in 4 analyzed patients. The observed pattern of V-H mutations suggested that nodal MZL, formerly deemed a malignancy of memory B cells, may arise from different subsets of marginal zone B cells-the naive B cells that express unmutated V-H genes-from memory B cells showing somatic mutations without intraclonal variation, and from germinal center B cells defined by their capacity to undergo the somatic hypermutation process. (C) 2001 by The American Society of Hematology.
引用
收藏
页码:781 / 786
页数:6
相关论文
共 43 条
[1]  
ARMITAGE JO, 1999, TEXT ATLAS LYMPHOMAS, P123
[2]   CD5+ low-grade marginal zone B-cell lymphomas with localized presentation [J].
Ballesteros, E ;
Osborne, BM ;
Matsushima, AY .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (02) :201-207
[3]   Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients [J].
Berger, F ;
Felman, P ;
Thieblemont, C ;
Pradier, T ;
Baseggio, L ;
Bryon, PA ;
Salles, G ;
Callet-Bauchu, E ;
Coiffier, B .
BLOOD, 2000, 95 (06) :1950-1956
[4]   Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process [J].
Bertoni, F ;
Cazzaniga, G ;
Bosshard, G ;
Roggero, E ;
Barbazza, R ;
DeBoni, M ;
Capella, C ;
Pedrinis, E ;
Cavalli, F ;
Biondi, A ;
Zucca, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) :830-836
[5]   Analysis of the human V-H gene repertoire - Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM(+) and CD5(-)/IgM(+) B cells [J].
Brezinschek, HP ;
Foster, SJ ;
Brezinschek, RI ;
Dorner, T ;
DomiatiSaad, R ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2488-2501
[6]   Primary nodal marginal zone lymphomas of splenic and MALT type [J].
Campo, E ;
Miquel, R ;
Krenacs, L ;
Sorbara, L ;
Raffeld, M ;
Jaffe, ES .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) :59-68
[7]  
Chan WC, 1997, BLOOD, V89, P3909
[8]   MONOCYTOID-B CELL LYMPHOMA - CLINICAL AND PROGNOSTIC FEATURES OF 21 PATIENTS [J].
COGLIATTI, SB ;
LENNERT, K ;
HANSMANN, ML ;
ZWINGERS, TL .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (08) :619-625
[9]   Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, ''minor'' D segments or D-D recombination [J].
Corbett, SJ ;
Tomlinson, IM ;
Sonnhammer, ELL ;
Buck, D ;
Winter, G .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 270 (04) :587-597
[10]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847